APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neprilysin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neprilysin Industry Growth and Trends Forecast to 2032

19 December 202574 pages

Choose your research edition.

Industry ResearchNeprilysin Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Neprilysin Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Neprilysin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neprilysin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neprilysin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neprilysin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neprilysin include Novartis AG, Theravance Biopharma Inc, Pharmaleads SA and Bioprojet SCR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neprilysin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neprilysin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neprilysin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neprilysin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neprilysin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neprilysin Market by Company

Novartis AG

Theravance Biopharma Inc

Pharmaleads SA

Bioprojet SCR

Neprilysin Segment by Type

TD-0714

STR-324

PL-265

LHW-090

Others

Neprilysin Segment by Application

Acute Heart Failure

Hypertension

Cancer Pain

Alzheimer's Disease

Others

Neprilysin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neprilysin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neprilysin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neprilysin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neprilysin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neprilysin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of TD-0714 Table 2. Major Company of STR-324 Table 3. Major Company of PL-265 Table 4. Major Company of LHW-090 Table 5. Major Company of Others Table 6. Global Neprilysin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Neprilysin Sales by Type (2021-2026) & (K Units) Table 8. Global Neprilysin Sales Market Share in Volume by Type (2021-2026) Table 9. Global Neprilysin Sales by Type (2021-2026) & (US$ Million) Table 10. Global Neprilysin Sales Market Share in Value by Type (2021-2026) Table 11. Global Neprilysin Price by Type (2021-2026) & (US$/Unit) Table 12. Global Neprilysin Sales by Type (2027-2032) & (K Units) Table 13. Global Neprilysin Sales Market Share in Volume by Type (2027-2032) Table 14. Global Neprilysin Sales by Type (2027-2032) & (US$ Million) Table 15. Global Neprilysin Sales Market Share in Value by Type (2027-2032) Table 16. Global Neprilysin Price by Type (2027-2032) & (US$/Unit) Table 17. North America Neprilysin Sales by Type (2021-2026) & (K Units) Table 18. North America Neprilysin Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Neprilysin Sales by Type (2021-2026) & (K Units) Table 20. Europe Neprilysin Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Neprilysin Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Neprilysin Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Neprilysin Sales by Type (2021-2026) & (K Units) Table 24. Latin America Neprilysin Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Neprilysin Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Neprilysin Sales by Type (2021-2026) & (US$ Million) Table 27. Neprilysin Industry Trends Table 28. Neprilysin Industry Drivers Table 29. Neprilysin Industry Opportunities and Challenges Table 30. Neprilysin Industry Restraints Table 31. Global Neprilysin Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Neprilysin Revenue Market Share by Company (2021-2026) Table 33. Global Neprilysin Sales by Company (2021-2026) & (K Units) Table 34. Global Neprilysin Sales Share by Company (2021-2026) Table 35. Global Neprilysin Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Neprilysin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Neprilysin Major Company Production Sites and Headquarters Table 38. Global Neprilysin Company, Product Type & Application Table 39. Global Neprilysin Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Neprilysin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Neprilysin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Neprilysin Sales by Region (2021-2026) & (K Units) Table 44. Global Neprilysin Sales Market Share in Volume by Region (2021-2026) Table 45. Global Neprilysin Sales by Region (2021-2026) & (US$ Million) Table 46. Global Neprilysin Sales Market Share in Value by Region (2021-2026) Table 47. Global Neprilysin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Neprilysin Sales by Region (2027-2032) & (K Units) Table 49. Global Neprilysin Sales Market Share in Volume by Region (2027-2032) Table 50. Global Neprilysin Sales by Region (2027-2032) & (US$ Million) Table 51. Global Neprilysin Sales Market Share in Value by Region (2027-2032) Table 52. Global Neprilysin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Neprilysin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Neprilysin Sales by Application (2021-2026) & (K Units) Table 55. Global Neprilysin Sales Market Share in Volume by Application (2021-2026) Table 56. Global Neprilysin Sales by Application (2021-2026) & (US$ Million) Table 57. Global Neprilysin Sales Market Share in Value by Application (2021-2026) Table 58. Global Neprilysin Price by Application (2021-2026) & (US$/Unit) Table 59. Global Neprilysin Sales by Application (2027-2032) & (K Units) Table 60. Global Neprilysin Sales Market Share in Volume by Application (2027-2032) Table 61. Global Neprilysin Sales by Application (2027-2032) & (US$ Million) Table 62. Global Neprilysin Sales Market Share in Value by Application (2027-2032) Table 63. Global Neprilysin Price by Application (2027-2032) & (US$/Unit) Table 64. North America Neprilysin Sales by Application (2021-2026) & (K Units) Table 65. North America Neprilysin Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Neprilysin Sales by Application (2021-2026) & (K Units) Table 67. Europe Neprilysin Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Neprilysin Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Neprilysin Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Neprilysin Sales by Application (2021-2026) & (K Units) Table 71. Latin America Neprilysin Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Neprilysin Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Neprilysin Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Neprilysin Product Portfolio Table 78. Novartis AG Recent Development Table 79. Theravance Biopharma Inc Company Information Table 80. Theravance Biopharma Inc Business Overview Table 81. Theravance Biopharma Inc Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Theravance Biopharma Inc Neprilysin Product Portfolio Table 83. Theravance Biopharma Inc Recent Development Table 84. Pharmaleads SA Company Information Table 85. Pharmaleads SA Business Overview Table 86. Pharmaleads SA Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Pharmaleads SA Neprilysin Product Portfolio Table 88. Pharmaleads SA Recent Development Table 89. Bioprojet SCR Company Information Table 90. Bioprojet SCR Business Overview Table 91. Bioprojet SCR Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bioprojet SCR Neprilysin Product Portfolio Table 93. Bioprojet SCR Recent Development Table 94. North America Neprilysin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. North America Neprilysin Sales by Country (2021-2026) & (K Units) Table 96. North America Neprilysin Sales Market Share by Country (2021-2026) Table 97. North America Neprilysin Sales Forecast by Country (2027-2032) & (K Units) Table 98. North America Neprilysin Sales Market Share Forecast by Country (2027-2032) Table 99. North America Neprilysin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Neprilysin Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Neprilysin Market Share by Country (2021-2026) Table 102. North America Neprilysin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Neprilysin Market Share Forecast by Country (2027-2032) Table 104. Europe Neprilysin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Europe Neprilysin Sales by Country (2021-2026) & (K Units) Table 106. Europe Neprilysin Sales Market Share by Country (2021-2026) Table 107. Europe Neprilysin Sales Forecast by Country (2027-2032) & (K Units) Table 108. Europe Neprilysin Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Neprilysin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Neprilysin Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Neprilysin Market Share by Country (2021-2026) Table 112. Europe Neprilysin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Neprilysin Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Neprilysin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Neprilysin Sales by Country (2021-2026) & (K Units) Table 116. Asia-Pacific Neprilysin Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Neprilysin Sales Forecast by Country (2027-2032) & (K Units) Table 118. Asia-Pacific Neprilysin Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Neprilysin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Neprilysin Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Neprilysin Market Share by Country (2021-2026) Table 122. Asia-Pacific Neprilysin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Neprilysin Market Share Forecast by Country (2027-2032) Table 124. Latin America Neprilysin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Latin America Neprilysin Sales by Country (2021-2026) & (K Units) Table 126. Latin America Neprilysin Sales Market Share by Country (2021-2026) Table 127. Latin America Neprilysin Sales Forecast by Country (2027-2032) & (K Units) Table 128. Latin America Neprilysin Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Neprilysin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Neprilysin Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Neprilysin Market Share by Country (2021-2026) Table 132. Latin America Neprilysin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Neprilysin Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Neprilysin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Neprilysin Sales by Country (2021-2026) & (K Units) Table 136. Middle East and Africa Neprilysin Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Neprilysin Sales Forecast by Country (2027-2032) & (K Units) Table 138. Middle East and Africa Neprilysin Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Neprilysin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Neprilysin Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Neprilysin Market Share by Country (2021-2026) Table 142. Middle East and Africa Neprilysin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Neprilysin Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Neprilysin Distributors List Table 147. Neprilysin Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Neprilysin Image Figure 2. Global Neprilysin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neprilysin Market Size (2021-2032) & (US$ Million) Figure 4. Global Neprilysin Sales (2021-2032) & (K Units) Figure 5. TD-0714 Image Figure 6. Global TD-0714 Sales YoY Growth (2021-2032) & (K Units) Figure 7. STR-324 Image Figure 8. Global STR-324 Sales YoY Growth (2021-2032) & (K Units) Figure 9. PL-265 Image Figure 10. Global PL-265 Sales YoY Growth (2021-2032) & (K Units) Figure 11. LHW-090 Image Figure 12. Global LHW-090 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Neprilysin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Neprilysin Market Share by Type 2025 VS 2032 Figure 17. North America Neprilysin Sales Market Share in Volume by Type in 2025 Figure 18. North America Neprilysin Sales Market Share in Value by Type in 2025 Figure 19. Europe Neprilysin Sales Market Share in Volume by Type in 2025 Figure 20. Europe Neprilysin Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Neprilysin Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Neprilysin Sales Market Share in Value by Type in 2025 Figure 23. Latin America Neprilysin Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Neprilysin Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Neprilysin Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Neprilysin Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Neprilysin Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Acute Heart Failure Image Figure 30. Global Acute Heart Failure Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hypertension Image Figure 32. Global Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 33. Cancer Pain Image Figure 34. Global Cancer Pain Sales YoY Growth (2021-2032) & (K Units) Figure 35. Alzheimer's Disease Image Figure 36. Global Alzheimer's Disease Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Neprilysin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Neprilysin Market Share by Application 2025 VS 2032 Figure 41. North America Neprilysin Sales Market Share in Volume by Application in 2025 Figure 42. North America Neprilysin Sales Market Share in Value by Application in 2025 Figure 43. Europe Neprilysin Sales Market Share in Volume by Application in 2025 Figure 44. Europe Neprilysin Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Neprilysin Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Neprilysin Sales Market Share in Value by Application in 2025 Figure 47. Latin America Neprilysin Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Neprilysin Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Neprilysin Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Neprilysin Sales Market Share in Value by Application in 2025 Figure 51. North America Neprilysin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Neprilysin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Neprilysin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Neprilysin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Neprilysin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Neprilysin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Neprilysin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Neprilysin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Neprilysin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Neprilysin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Neprilysin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Neprilysin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Neprilysin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Neprilysin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Neprilysin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Neprilysin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Neprilysin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Neprilysin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Neprilysin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Neprilysin Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Neprilysin Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Neprilysin Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • TD-0714
  • STR-324
  • PL-265
  • LHW-090
  • Others
Applications
  • Acute Heart Failure
  • Hypertension
  • Cancer Pain
  • Alzheimer's Disease
  • Others
Companies covered
  • Novartis AG
  • Theravance Biopharma Inc
  • Pharmaleads SA
  • Bioprojet SCR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neprilysin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neprilysin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neprilysin Market by Type
  6. 1.3.1 TD-0714
  7. 1.3.2 STR-324
  8. 1.3.3 PL-265
  9. 1.3.4 LHW-090
  10. 1.3.5 Others
  11. 1.4 Global Neprilysin Market Size by Type
  12. 1.4.1 Global Neprilysin Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Neprilysin Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Neprilysin Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Neprilysin Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Neprilysin Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Neprilysin Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Neprilysin Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Neprilysin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neprilysin Industry Trends
  2. 2.2 Neprilysin Industry Drivers
  3. 2.3 Neprilysin Industry Opportunities and Challenges
  4. 2.4 Neprilysin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neprilysin Revenue (2021-2026)
  2. 3.2 Global Top Players by Neprilysin Sales (2021-2026)
  3. 3.3 Global Top Players by Neprilysin Price (2021-2026)
  4. 3.4 Global Neprilysin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neprilysin Major Company Production Sites & Headquarters
  6. 3.6 Global Neprilysin Company, Product Type & Application
  7. 3.7 Global Neprilysin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neprilysin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neprilysin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neprilysin Tier 1, Tier 2, and Tier 3
4 Neprilysin Regional Status and Outlook
  1. 4.1 Global Neprilysin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neprilysin Historic Market Size by Region
  3. 4.2.1 Global Neprilysin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neprilysin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neprilysin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neprilysin Forecasted Market Size by Region
  7. 4.3.1 Global Neprilysin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neprilysin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neprilysin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neprilysin by Application
  1. 5.1 Neprilysin Market by Application
  2. 5.1.1 Acute Heart Failure
  3. 5.1.2 Hypertension
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Alzheimer's Disease
  6. 5.1.5 Others
  7. 5.2 Global Neprilysin Market Size by Application
  8. 5.2.1 Global Neprilysin Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Neprilysin Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Neprilysin Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Neprilysin Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Neprilysin Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Neprilysin Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Neprilysin Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Neprilysin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Neprilysin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Neprilysin Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Theravance Biopharma Inc
  8. 6.2.1 Theravance Biopharma Inc Company Information
  9. 6.2.2 Theravance Biopharma Inc Business Overview
  10. 6.2.3 Theravance Biopharma Inc Neprilysin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Theravance Biopharma Inc Neprilysin Product Portfolio
  12. 6.2.5 Theravance Biopharma Inc Recent Developments
  13. 6.3 Pharmaleads SA
  14. 6.3.1 Pharmaleads SA Company Information
  15. 6.3.2 Pharmaleads SA Business Overview
  16. 6.3.3 Pharmaleads SA Neprilysin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pharmaleads SA Neprilysin Product Portfolio
  18. 6.3.5 Pharmaleads SA Recent Developments
  19. 6.4 Bioprojet SCR
  20. 6.4.1 Bioprojet SCR Company Information
  21. 6.4.2 Bioprojet SCR Business Overview
  22. 6.4.3 Bioprojet SCR Neprilysin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bioprojet SCR Neprilysin Product Portfolio
  24. 6.4.5 Bioprojet SCR Recent Developments
7 North America by Country
  1. 7.1 North America Neprilysin Sales by Country
  2. 7.1.1 North America Neprilysin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neprilysin Sales by Country (2021-2026)
  4. 7.1.3 North America Neprilysin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neprilysin Market Size by Country
  6. 7.2.1 North America Neprilysin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neprilysin Market Size by Country (2021-2026)
  8. 7.2.3 North America Neprilysin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neprilysin Sales by Country
  2. 8.1.1 Europe Neprilysin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neprilysin Sales by Country (2021-2026)
  4. 8.1.3 Europe Neprilysin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neprilysin Market Size by Country
  6. 8.2.1 Europe Neprilysin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neprilysin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neprilysin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neprilysin Sales by Country
  2. 9.1.1 Asia-Pacific Neprilysin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neprilysin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neprilysin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neprilysin Market Size by Country
  6. 9.2.1 Asia-Pacific Neprilysin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neprilysin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neprilysin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neprilysin Sales by Country
  2. 10.1.1 South America Neprilysin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neprilysin Sales by Country (2021-2026)
  4. 10.1.3 South America Neprilysin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neprilysin Market Size by Country
  6. 10.2.1 South America Neprilysin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neprilysin Market Size by Country (2021-2026)
  8. 10.2.3 South America Neprilysin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neprilysin Sales by Country
  2. 11.1.1 Middle East and Africa Neprilysin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neprilysin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neprilysin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neprilysin Market Size by Country
  6. 11.2.1 Middle East and Africa Neprilysin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neprilysin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neprilysin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neprilysin Value Chain Analysis
  2. 12.1.1 Neprilysin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neprilysin Production Mode & Process
  7. 12.2 Neprilysin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neprilysin Distributors
  10. 12.2.3 Neprilysin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst